IMRF
DNLI icon

Illinois Municipal Retirement Fund’s Denali Therapeutics DNLI Stock Holding History

Illinois Municipal Retirement Fund’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-7,510
Closed -$335K – 807
2021
Q4 		$335K Hold
7,510
– – 0.01% 781
2021
Q3 		$379K Buy
7,510
+3,060
+69% +$172K 0.01% 737
2021
Q2 		$349K Hold
4,450
– – 0.01% 771
2021
Q1 		$254K Buy
+4,450
New +$298K 0.01% 832

Other funds holding DNLI

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Illinois Municipal Retirement Fund's DNLI Position: Q1 2022 in Review

Illinois Municipal Retirement Fund sold out of Denali Therapeutics (DNLI) in Q1 2022, closing a stake of 7,510 shares — an estimated $335K sold.

Illinois Municipal Retirement Fund first reported a position in DNLI in Q1 2021 and held it in 4 quarters. The position peaked at $379K in Q3 2021. 190 funds tracked by Wall St. Rank hold DNLI as of Q1 2022.

  • Illinois Municipal Retirement Fund reported no remaining Denali Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Illinois Municipal Retirement Fund sold 7,510 Denali Therapeutics shares in Q1 2022, an estimated $335K.
  • Illinois Municipal Retirement Fund first reported a position in Denali Therapeutics in Q1 2021 and held it in 4 quarters.
  • Illinois Municipal Retirement Fund's Denali Therapeutics position peaked at $379K in Q3 2021.
  • 190 funds tracked by Wall St. Rank held Denali Therapeutics as of Q1 2022.

Based on Illinois Municipal Retirement Fund's 13F filing for Q1 2022, filed 29 Apr 2022.